These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6980595)

  • 1. Possible new markers in trophoblastic diseases.
    Inaba N; Ishige H; Ijichi M; Satoh N; Katoh T; Sekiya S; Shirotake S; Ohkawa R; Takamizawa H; Nitoh A; Renk T; Bohn H
    Am J Obstet Gynecol; 1982 Aug; 143(8):973-4. PubMed ID: 6980595
    [No Abstract]   [Full Text] [Related]  

  • 2. Pregnancy-specific beta-1-glycoprotein in trophoblastic disease.
    Rutanen EM; Seppälä M
    J Clin Endocrinol Metab; 1980 Jan; 50(1):57-61. PubMed ID: 6243133
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytophotometric DNA determination of trophoblastic neoplasia.
    Nishiya I; Moriya S; Yamashita K; Kikuchi T
    Gynecol Oncol; 1977 Jun; 5(2):103-8. PubMed ID: 195868
    [No Abstract]   [Full Text] [Related]  

  • 4. Pregnancy-specific proteins as markers for gestational trophoblastic disease.
    Horne CH; Rankin R; Bremner RD
    Int J Gynecol Pathol; 1984; 3(1):27-40. PubMed ID: 6203853
    [No Abstract]   [Full Text] [Related]  

  • 5. Nuclear DNA content of trophoblastic tumors.
    Sugimori H; Kashimura Y; Kashimura M; Taki I
    Acta Cytol; 1978; 22(6):542-5. PubMed ID: 216204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of concanavalin A-unbound serum pregnancy-specific beta 1-glycoprotein in the assessment of trophoblastic diseases.
    Englebienne P; Doyen G
    Ric Clin Lab; 1984; 14(3):561-3. PubMed ID: 6098001
    [No Abstract]   [Full Text] [Related]  

  • 7. Trophoblastic disease monitoring: Evaluation of pregnancy-specific beta 1-glycoprotein.
    O'Brien TJ; Engvall E; Schlaerth JB; Morrow CP
    Am J Obstet Gynecol; 1980 Oct; 138(3):313-20. PubMed ID: 6251725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gestational trophoblastic disease: selected clinical aspects and chorionic gondadotropin test methods.
    Brewer JI; Halpern B; Torok EE
    Curr Probl Cancer; 1979 Apr; 3(10):1-42. PubMed ID: 223814
    [No Abstract]   [Full Text] [Related]  

  • 9. HCG assays. A plea for uniformity.
    Bock JL
    Am J Clin Pathol; 1990 Mar; 93(3):432-3. PubMed ID: 1689949
    [No Abstract]   [Full Text] [Related]  

  • 10. Lectin binding in tissues from hydatidiform mole, invasive mole and choriocarcinoma to concanavalin-A, wheat germ agglutinin and peanut agglutinin.
    Juan FT; Hoshina M; Manalo AM; Mochizuki M
    Asia Oceania J Obstet Gynaecol; 1989 Dec; 15(4):383-93. PubMed ID: 2560369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of the new placental proteins in trophoblastic disease.
    Tsakok FH; Koh S; Chua SE; Ratnam SS; Teisner B; Jones GR; Sinosich M; Grudzinskas JG
    Br J Obstet Gynaecol; 1983 May; 90(5):483-6. PubMed ID: 6189512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical studies of fetal trophoblast and maternal decidua in hydatidiform mole and choriocarcinoma.
    Bulmer JN; Johnson PM; Sasagawa M; Takeuchi S
    Placenta; 1988; 9(2):183-200. PubMed ID: 3041405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of pregnancy specific beta1-glycoprotein in formalin-fixed tissues.
    Horne CH; Towler CM; Milne GD
    J Clin Pathol; 1977 Jan; 30(1):19-23. PubMed ID: 190273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of incompletely sialylated human chorionic gonadotropin by peanut agglutinin in choriocarcinoma.
    Nishimura R; Mizuochi T; Utsunomiya T; Ide K; Kobata A; Mochizuki M
    Jpn J Exp Med; 1985 Apr; 55(2):75-8. PubMed ID: 4046212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental protein 5 in gestational trophoblastic disease: localization and circulating levels.
    Nisbet AD; Bremner RD; Horne CH; Brooker D; Twiggs LB; Okagaki T
    Am J Obstet Gynecol; 1982 Oct; 144(4):396-401. PubMed ID: 6289667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytological distribution of chorionic gonadotropin subunit and placental lactogen messenger RNA in neoplasms derived from human placenta.
    Hoshina M; Hussa R; Pattillo R; Boime I
    J Cell Biol; 1983 Oct; 97(4):1200-6. PubMed ID: 6619191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of the production of chorionic gonadotropin by the cells of trophoblastic tumors (immunohistochemical research)].
    Pozharisskiĭ KM; Zueva EE; Nikitin AIu
    Vopr Onkol; 1988; 34(8):945-51. PubMed ID: 2844022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
    Than GN; Csaba IF; Bohn H; Szabó DG; Szalmásy M; Menczer G
    Oncodev Biol Med; 1982; 3(4):315-23. PubMed ID: 6291007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyamines and nucleic acids in gestational trophoblastic tumors.
    Romano M; Cecco L; Cerra M; Pasquinelli R; Pagnano AM; Paladini A
    Tumori; 1985 Feb; 71(1):35-8. PubMed ID: 2984816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.